BMS-223131
BMS-223131 (Compound 1) is a potent maxi-K potassium channel opener. BMS-223131 has a strong inhibitory effect on the CYP2C9 enzyme (IC50 = 1.7 μM) and also shows varying degrees of inhibition on other common CYP enzymes such as CYP1A2, CYP2C19, CYP2D6, and CYP3A4. BMS-223131 can enhance the outward current mediated by maxi-K, by promoting K+ efflux to hyperpolarize the cell membrane and reducing Ca2+ influx. BMS-223131 can be used for the research of neurological disease, such as stroke[1].
Product Specifications
CAS Number
275375-69-4
UNSPSC
12352005
Target
Cytochrome P450; Potassium Channel
Related Pathways
Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
O=C1NC2=C(C=C(C(F)(F)F)C=C2)C(C3=CC(Cl)=CC=C3O)=C1CCO
Molecular Formula
C18H13ClF3NO3
Molecular Weight
383.75
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CYP1A2; CYP2C19; CYP2C9; CYP2D6; CYP3A4
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human SMIM4 shRNA (UAS) - Lentiviral human SMIM4 shRNA (UAS, iRFP) plasmid
